calusterone
← Previous: butyryl fentanyl | 🏠 All Substances | 📊 Complete Table | Next: camazepam →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Added to Database | December 30, 2025 |
| Source Last Updated | May 28, 2024 |
| GUID | e8ac3d06-3c2b-439e-b7cc-c25c09cf90af |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 0678G6Q58A · CAS: 17021-26-0
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C21H32O2 |
| Molecular Weight | 316.5 g/mol |
| IUPAC Name | (7S,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13,17-tetramethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
| InChIKey | IVFYLRMMHVYGJH-PVPPCFLZSA-N |
📊 Complete Table | 🏠 All Substances
Substance 250 of 880